Sirkku Jyrkkiö

Adjuvant Docetaxel or Vinorelbine with or without Trastuzumab for Breast Cancer

Heikki Joensuu, Pirkko‐Liisa Kellokumpu‐Lehtinen, Petri Bono et al. · New England Journal of Medicine · 2006 · 1.4K citations

Medicine, Oncology, Pharmacology +16

Fluorouracil, Epirubicin, and Cyclophosphamide With Either Docetaxel or Vinorelbine, With or Without Trastuzumab, As Adjuvant Treatments of Breast Cancer: Final Results of the FinHer Trial

Heikki Joensuu, Petri Bono, Vesa Kataja et al. · Journal of Clinical Oncology · 2009 · 459 citations · Full text

Medicine, Oncology, Pharmacology +17

Prediction of overall survival for patients with metastatic castration-resistant prostate cancer: development of a prognostic model through a crowdsourced challenge with open clinical trial data

Justin Guinney, Tao Wang, Teemu D. Laajala et al. · The Lancet Oncology · 2016 · 144 citations · Full text

Public Health, Biostatistics, Oncology +17

Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma

Leo Meriranta, Amjad Alkodsi, Annika Pasanen et al. · Blood · 2021 · 129 citations · Full text

Medicine, Molecular Biology, Oncology +15

Metabolic characterization of childhood brain tumors

Meri Utriainen, Liisa Metsähonkala, Toivo T. Salmi et al. · Cancer · 2002 · 118 citations · Full text

Medicine, Nuclear Medicine, Oncology +17